ADiTx Therapeutics, Inc (ADTX)

Etorro trading 970x250
ADiTx Therapeutics, Inc (ADTX) Logo

About ADiTx Therapeutics, Inc

ADiTx Therapeutics, Inc., a life sciences company, develops technologies focuses on improving the health of the immune system through immune monitoring and reprogramming. It is developing AditxtScore that allow individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach, which mimics the way the body naturally induces tolerance to its own tissues. The company is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies. It has a license agreement with Loma Linda University and Leland Stanford Junior University. ADiTx Therapeutics, Inc. was founded in 2017 and is headquartered in Mountain View, California. Address: 2569 Wyandotte Street, Mountain View, CA, United States, 94043

ADiTx Therapeutics, Inc News and around…

Latest news about ADiTx Therapeutics, Inc (ADTX) common stock and company :

The Largest Law Enforcement Agency in the State of Kansas, Johnson County Sherriff’s Office, to Become First in the Nation to Deploy AditxtScore™ for Immune Scoring for its Employees and First Respond
22 Nov, 2021 FinancialContent

Aditxt, Inc. (“Aditxt” or the “Company”) (Nasdaq: ADTX), a biotech innovation company that improves the health of the immune system, announced today that the Johnson County Sherriff’s Office, the largest law enforcement agency in the State of Kansas with over 700 employees, will become the first agency in the Nation to deploy AditxtScore™ for assessing the immune status for COVID-19 in its employees.

The Largest Law Enforcement Agency in the State of Kansas, Johnson County Sherriff’s Office, to Become First in the Nation to Deploy AditxtScore™ for Immune Scoring for its Employees and First Responders
22 Nov, 2021 Yahoo! Finance

RICHMOND, Va., November 22, 2021--Aditxt, Inc. ("Aditxt" or the "Company") (Nasdaq: ADTX), a biotech innovation company that improves the health of the immune system, announced today that the Johnson County Sherriff’s Office, the largest law enforcement agency in the State of Kansas with over 700 employees, will become the first agency in the Nation to deploy AditxtScore™ for assessing the immune status for COVID-19 in its employees.

Aditxt Acquisition-Partner's At-Home COVID-19 Drug Fails In Late-Stage Trial
12 Nov, 2021 FinancialContent

Aditxt Inc(NASDAQ: ADTX) has announceddata from Phase 3 PRESECO trialevaluating oral Avigan/Reeqonus (favipiravir) ...

12 Health Care Stocks Moving In Friday's Intraday Session
12 Nov, 2021 FinancialContent

Gainers SOC Telemed (NASDAQ:TLMD) stock increased by 30.04% to $2.77 during Friday's regular session. The current ...

Aditxt Webinar at 2pm ET to Explore PRESECO Results
12 Nov, 2021 FinancialContent

Aditxt, Inc. (“Aditxt”) (Nasdaq: ADTX), has announced a webinar at 2pm ET this afternoon to discuss its earlier announcement today.

Aditxt Provides an Update Regarding its Target Acquisition AiPharma Global Holdings LLC
12 Nov, 2021 FinancialContent

Aditxt, Inc. (“Aditxt”) (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, today announced that the global Phase 3 PRESECO (PREventing SEvere COVID-19) trial evaluating oral Avigan®/Reeqonus™ (favipiravir) as a potential at-home therapy for patients with mild-to-moderate COVID-19, which was being run by Appili Therapeutics, Inc. (“Appili”)(TSX: APLI), a consortium partner of AiPharma Global Holdings LLC (“AiPharma Global”), did not achieve statistical significance on the primary endpoint of time to sustained clinical recovery. Additional analyses of the trial data are ongoing.

12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Nov, 2021 FinancialContent

Gainers Sundial Growers (NASDAQ:SNDL) stock increased by 28.49% to $0.93 during Friday's pre-market session. The ...

12 Health Care Stocks Moving In Monday's Intraday Session
08 Nov, 2021 FinancialContent

Gainers PetVivo Holdings (NASDAQ:PETV) shares increased by 27.75% to $4.51 during Monday's regular session. As of 11:30 EST, this ...

12 Health Care Stocks Moving In Monday's Pre-Market Session
08 Nov, 2021 FinancialContent

Gainers Autolus Therapeutics (NASDAQ:AUTL) stock rose 21.04% to $6.73 during Monday's pre-market session. The ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
08 Nov, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back, trader! We're starting off the week strong with a dive into the biggest pre-market stock movers for Monday. The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

92 Biggest Movers From Friday
08 Nov, 2021 FinancialContent

Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares jumped 99.8% to close at $9.99 on Friday. Mainz Biomed priced its initial public ...

64 Stocks Moving In Friday's Mid-Day Session
05 Nov, 2021 FinancialContent

Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 198.4% to $14.92. Mainz Biomed priced its initial public offering of 2 ...

28 Stocks Moving in Friday's Pre-Market Session
05 Nov, 2021 FinancialContent

Gainers ReWalk Robotics Ltd. (NASDAQ: RWLK) rose 65.8% to $2.14 in pre-market trading after the company announced its ReBoot ...

Aditxt Partners With CLX Health to Offer AditxtScore™ for COVID-19 Immune Monitoring Service Through CLX’s TrustAssure™ Platform
03 Nov, 2021 FinancialContent

Aditxt, Inc. (Nasdaq: ADTX), (“Aditxt” or the “Company”) a biotechnology innovation company with a mission to improve the health of the immune system, announced today a partnership with CLX Health, a developer of cloud-based solutions. The goal of this partnership is to accelerate the market availability of AditxtScore™ for COVID-19 through CLX Health’s TrustAssure Solution Suite. TrustAssure Solution Suite is a multi-stakeholder engagement platform that consumers, laboratories, healthcare providers, health plans, and public health authorities can access to communicate vital health information for real-time risk assessment to manage the COVID-19 pandemic and other public health emergencies.

Aditxt Announces Closing of $4.25 Million Public Offering
20 Oct, 2021 FinancialContent

Aditxt, Inc. (“Aditxt”) (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, announced today the closing of its previously announced underwritten public offering of 2,833,333 shares of its common stock at a public offering price of $1.50 per share, for gross proceeds of $4.25 million, before deducting underwriting discounts and offering expenses.

Aditxt to Present at the Dawson James 6th Annual Small Cap Growth Conference in Florida on October 21, 2021
20 Oct, 2021 FinancialContent

Aditxt, Inc. (“Aditxt” or the “Company”) (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, announced today the Company’s Co-Founder, Chairman, and CEO Amro Albanna will present at the Dawson James Small Cap Growth Conference on Thursday, October 21, 2021 at 2:50 p.m. ET in Jupiter, Florida. Mr. Albanna will also participate in 1x1 meetings with investors and analysts.

Aditxt Announces Pricing of $4.25 Million Public Offering
18 Oct, 2021 FinancialContent

Aditxt, Inc. (“Aditxt”) (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, announced today the pricing of an underwritten public offering of 2,833,333 shares of its common stock at a public offering price of $1.50 per share, for gross proceeds of $4.25 million, before deducting underwriting discounts and offering expenses.

10 Top Penny Stocks To Watch This Week With Potential Biotech Catalysts
17 Oct, 2021 FinancialContent
22 Stocks Moving in Friday's Pre-Market Session
15 Oct, 2021 FinancialContent

Gainers LM Funding America, Inc. (NASDAQ: LMFA) rose 39.5% to $4.80 in pre-market trading after declining around 15% on Thursday. ...

12 Health Care Stocks Moving In Wednesday's Intraday Session
13 Oct, 2021 FinancialContent

Gainers Statera BioPharma (NASDAQ:STAB) shares increased by 16.92% to $3.16 during Wednesday's regular session. The ...

15 Stocks Moving in Monday's Pre-Market Session
11 Oct, 2021 FinancialContent

Gainers Trevi Therapeutics, Inc. (NASDAQ: TRVI) rose 32.5% to $1.59 in pre-market trading after the company filed Friday to ...

Best Penny Stocks To Buy This Week? 10 With Potential Biotech Catalysts
10 Oct, 2021 FinancialContent
Aditxt to Present at the LD Micro Main Event in Los Angeles on October 13, 2021
07 Oct, 2021 FinancialContent

Aditxt, Inc. (“Aditxt” or the “Company”) (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, announced today the Company’s Co-Founder, Chairman, and CEO Amro Albanna will present at the LD Micro Main Event in person on October 13, 2021 at 8:30 AM PT / 11:30 AM ET on Track 1. Mr. Albanna will also participate in 1x1 meetings with investors and analysts.

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
06 Oct, 2021 FinancialContent

Gainers Voyager Therapeutics (NASDAQ:VYGR) shares increased by 46.15% to $3.61 during Wednesday's pre-market ...

Are Penny Stocks Worth It? Here’s 3 to Know About in October
05 Oct, 2021 FinancialContent
Aditxt Shares Surge On AiPharma Acquisition, Holder Of COVID-19 Candidate
05 Oct, 2021 FinancialContent

Aditxt Inc(NASDAQ: ADTX) hasagreed to acquireAiPharma Global Holdings LLC, focused on discovering, developing, and ...

ADTX Stock: The Huge Covid-19 News Lifting Aditxt Today
05 Oct, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today, investors in Aditxt and ADTX stock are seeing impressive gains following an announced acquisition of a company with a Covid-19 drug. The post ADTX Stock: The Huge Covid-19 News Lifting Aditxt Today appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

AiPharma Signs Binding Agreement To Sell To Aditxt Inc (Nasdaq: ADTX). AiPharma Is The Rights Holder Of Antiviral Tablet Avigan / Reeqonus / Qifenda That Has Treated Over 1.5M COVID-19 Patients Since The Outbreak.
05 Oct, 2021 Yahoo! Finance

AiPharma Global Holdings LLC ("AiPharma") a company focused on discovering, developing and commercializing antiviral therapies across a broad spectrum of infectious diseases today announced it has entered a binding agreement to sell all of its assets through the sale of one of its wholly owned group subsidaries, to Aditxt Inc. (Nasdaq: ADTX). Aditxt is a biotech innovation company with a mission to improve the health of the immune system.

Aditxt Signs a Transaction Agreement to Acquire AiPharma, Rights Holder of Antiviral Tablet Avigan/Reeqonus/Qifenda Used in the Treatment of Over 1.5 Million COVID-19 Patients Outside the U.S. and Can
05 Oct, 2021 FinancialContent

Aditxt, Inc. (“Aditxt”) (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, today announced it has entered into a transaction agreement to reach a definitive agreement by the end of November 2021 to acquire a subsidiary (“AiPharma”) of AiPharma Global Holdings LLC (“AiPharma Global”) which is to own all of the assets of AiPharma Global, a company focused on discovering, developing and commercializing antiviral therapies across a broad spectrum of infectious diseases.

Aditxt Signs a Transaction Agreement to Acquire AiPharma, Rights Holder of Antiviral Tablet Avigan/Reeqonus/Qifenda Used in the Treatment of Over 1.5 Million COVID-19 Patients Outside the U.S. and Canada
05 Oct, 2021 Yahoo! Finance

RICHMOND, Va., October 05, 2021--Aditxt, Inc. ("Aditxt") (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, today announced it has entered into a transaction agreement to reach a definitive agreement by the end of November 2021 to acquire a subsidiary ("AiPharma") of AiPharma Global Holdings LLC ("AiPharma Global") which is to own all of the assets of AiPharma Global, a company focused on discovering, developing and commercializing antiviral t

ADiTx Therapeutics, Inc (ADTX) is a NASDAQ Common Stock listed in , ,

970x250